ArticleConflict and health2025
Health care without medicine: the impact of war on Sudan's pharmaceutical manufacturing and supply.
Article in Conflict and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Availability of essential medicines in conflict-affected african regions: a systematic review and meta-analysis.Conflict and health · 2026Review
- Post-conflict restoration of health facilities in Amhara region, Ethiopia.BMC research notes · 2026Article
- Adherence to anti-seizure medications among pediatric epilepsy patients during the Sudan armed conflict.Conflict and health · 2026Article
- A multi-state cross-sectional assessment of essential medicine availability in Sudan during armed conflict.Scientific reports · 2026Article
- The Effect of Conflict on Medical Services for People Living With Advanced HIV Disease and Cryptococcal Meningitis in Ethiopia's Tigray Region: A Qualitative Study of Healthcare Providers.Open forum infectious diseases · 2026Article
- Availability and readiness of healthcare services at primary healthcare centers during the Sudan war: a cross-sectional study.BMC primary care · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArmed conflict in Sudan since April 2023 has led to the widespread disruption of health care services, the destruction of public and private health care infrastructure nationwide, and the targeting of health care personnel. This study examines the impact of the conflict on a less publicized sector of Sudan's health system: the national pharmaceutical manufacturing and supply chain.
methodsResearch interviews were conducted with representatives of 4 companies engaged in pharmaceutical manufacturing and/or supply in Sudan, in addition to a review of primary information from medical regulators and industry associations. Based on these interviews, 3 case studies are presented; insights from the fourth interview inform the study overall.
resultsAll 4 companies reported significant impacts on their operations, as well as on other companies in the pharmaceutical sector. Domestic pharmaceutical manufacturing has effectively come to a halt, leading to the non-availability of certain drugs in parts of the country. Manufacturers have shifted course to focus on imports, but heavy losses of domestically stored inventory and an inability to distribute medicines to large parts of the country have had a significant impact on pharmaceutical supply to retail pharmacies, public and private sector health facilities, and the National Medical Supplies Fund (NMSF).
conclusionsSudan's pharmaceutical manufacturing industry has been devasted. Although less visible than hospitals and medical personnel, the effects on the pharmaceutical sector are consequential for Sudan's health sector, particularly for chronic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.